Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 98.63 Million CAD | 90.77% |
| 2022 | 49.46 Million CAD | -44.2% |
| 2021 | 75.19 Million CAD | -27.94% |
| 2020 | 127.02 Million CAD | 43.61% |
| 2019 | 90.3 Million CAD | -2.81% |
| 2018 | 94.23 Million CAD | -4.1% |
| 2017 | 97.59 Million CAD | -1.9% |
| 2016 | 98.23 Million CAD | 10.94% |
| 2015 | 95.92 Million CAD | -24.83% |
| 2014 | 117.66 Million CAD | -23.17% |
| 2013 | 128.72 Million CAD | -12.75% |
| 2012 | 180.3 Million CAD | -13.03% |
| 2011 | 144.41 Million CAD | -18.71% |
| 2010 | 254.52 Million CAD | -12.37% |
| 2009 | 290.23 Million CAD | 40.23% |
| 2008 | 207.12 Million CAD | -0.62% |
| 2007 | 208.42 Million CAD | -24.53% |
| 2006 | 276.14 Million CAD | 2.81% |
| 2005 | 268.61 Million CAD | 19.6% |
| 2004 | 224.59 Million CAD | 20.21% |
| 2003 | 186.83 Million CAD | -26.28% |
| 2002 | 253.44 Million CAD | 11.7% |
| 2001 | 226.9 Million CAD | 14.36% |
| 2000 | 198.41 Million CAD | -13.71% |
| 1999 | 229.95 Million CAD | -31.52% |
| 1998 | 335.77 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 38.61 Million CAD | 24.04% |
| 2024 Q1 | 30.13 Million CAD | 20.58% |
| 2023 Q1 | 32.44 Million CAD | 333.47% |
| 2023 Q4 | 19.41 Million CAD | -39.8% |
| 2023 FY | - CAD | 90.77% |
| 2023 Q3 | 32.24 Million CAD | 104.02% |
| 2023 Q2 | 15.8 Million CAD | -51.28% |
| 2022 Q1 | 20.1 Million CAD | -32.71% |
| 2022 Q4 | 7.48 Million CAD | -4.46% |
| 2022 Q2 | 17.69 Million CAD | -11.99% |
| 2022 Q3 | 7.83 Million CAD | -55.73% |
| 2022 FY | - CAD | -44.2% |
| 2021 Q1 | 27.92 Million CAD | -28.12% |
| 2021 FY | - CAD | -27.94% |
| 2021 Q2 | 17.94 Million CAD | -35.72% |
| 2021 Q4 | 29.87 Million CAD | 53.66% |
| 2021 Q3 | 19.44 Million CAD | 8.33% |
| 2020 Q3 | 64.01 Million CAD | 654.92% |
| 2020 Q4 | 38.84 Million CAD | -39.33% |
| 2020 Q2 | 8.48 Million CAD | -58.69% |
| 2020 Q1 | 20.52 Million CAD | -13.06% |
| 2020 FY | - CAD | 43.61% |
| 2019 Q2 | 24.37 Million CAD | 22.59% |
| 2019 Q1 | 19.88 Million CAD | -11.03% |
| 2019 Q4 | 23.6 Million CAD | -2.12% |
| 2019 FY | - CAD | -2.81% |
| 2019 Q3 | 24.12 Million CAD | -1.03% |
| 2018 Q1 | 20.16 Million CAD | -28.05% |
| 2018 FY | - CAD | -4.1% |
| 2018 Q2 | 27.38 Million CAD | 35.8% |
| 2018 Q3 | 24.55 Million CAD | -10.34% |
| 2018 Q4 | 22.34 Million CAD | -9.0% |
| 2017 Q4 | 28.03 Million CAD | 16.33% |
| 2017 Q1 | 21.6 Million CAD | -18.06% |
| 2017 Q2 | 24.95 Million CAD | 15.51% |
| 2017 FY | - CAD | -1.9% |
| 2017 Q3 | 24.09 Million CAD | -3.45% |
| 2016 FY | - CAD | 10.94% |
| 2016 Q4 | 26.36 Million CAD | -4.48% |
| 2016 Q2 | 28.92 Million CAD | 72.31% |
| 2016 Q3 | 27.6 Million CAD | -4.58% |
| 2016 Q1 | 16.78 Million CAD | -31.43% |
| 2015 FY | - CAD | -24.83% |
| 2015 Q4 | 24.48 Million CAD | -7.31% |
| 2015 Q2 | 23.35 Million CAD | 42.11% |
| 2015 Q1 | 16.43 Million CAD | -54.26% |
| 2015 Q3 | 26.41 Million CAD | 13.12% |
| 2014 FY | - CAD | -23.17% |
| 2014 Q4 | 35.91 Million CAD | -19.45% |
| 2014 Q3 | 44.59 Million CAD | 614.37% |
| 2014 Q2 | 6.24 Million CAD | -82.11% |
| 2014 Q1 | 34.89 Million CAD | 6.83% |
| 2013 Q3 | 42.95 Million CAD | 2.52% |
| 2013 FY | - CAD | -12.75% |
| 2013 Q4 | 32.65 Million CAD | -23.96% |
| 2013 Q2 | 41.89 Million CAD | 6.07% |
| 2013 Q1 | 39.49 Million CAD | -16.46% |
| 2012 Q4 | 47.27 Million CAD | 24.96% |
| 2012 Q2 | 44.72 Million CAD | -18.01% |
| 2012 FY | - CAD | -13.03% |
| 2012 Q1 | 54.55 Million CAD | 118.33% |
| 2012 Q3 | 37.83 Million CAD | -15.41% |
| 2011 Q3 | 60.97 Million CAD | -6.3% |
| 2011 Q2 | 65.08 Million CAD | 59.48% |
| 2011 FY | - CAD | -18.71% |
| 2011 Q4 | 24.98 Million CAD | -59.02% |
| 2011 Q1 | 40.8 Million CAD | -45.27% |
| 2010 Q4 | 74.55 Million CAD | 36.13% |
| 2010 Q1 | 63.49 Million CAD | 1.28% |
| 2010 FY | - CAD | -12.37% |
| 2010 Q2 | 61.7 Million CAD | -2.83% |
| 2010 Q3 | 54.76 Million CAD | -11.24% |
| 2009 FY | - CAD | 40.23% |
| 2009 Q1 | 60.94 Million CAD | -3.02% |
| 2009 Q2 | 84.26 Million CAD | 38.27% |
| 2009 Q3 | 82.78 Million CAD | -1.75% |
| 2009 Q4 | 62.69 Million CAD | -24.27% |
| 2008 Q1 | 50.3 Million CAD | 274.62% |
| 2008 FY | - CAD | -0.62% |
| 2008 Q4 | 62.83 Million CAD | 21.19% |
| 2008 Q3 | 51.85 Million CAD | 13.59% |
| 2008 Q2 | 45.64 Million CAD | -9.25% |
| 2007 FY | - CAD | -24.53% |
| 2007 Q3 | 394.42 Million CAD | 536.32% |
| 2007 Q4 | 13.42 Million CAD | -96.6% |
| 2007 Q2 | 61.98 Million CAD | -5.25% |
| 2007 Q1 | 65.42 Million CAD | -11.24% |
| 2006 Q2 | 70.33 Million CAD | 20.31% |
| 2006 Q4 | 73.7 Million CAD | -9.16% |
| 2006 Q1 | 58.46 Million CAD | -1.98% |
| 2006 Q3 | 81.13 Million CAD | 15.36% |
| 2006 FY | - CAD | 2.81% |
| 2005 Q2 | 79.57 Million CAD | 34.55% |
| 2005 Q1 | 59.14 Million CAD | 13.76% |
| 2005 FY | - CAD | 19.6% |
| 2005 Q3 | 67.85 Million CAD | -14.73% |
| 2005 Q4 | 59.64 Million CAD | -12.11% |
| 2004 Q1 | 50.98 Million CAD | 0.75% |
| 2004 Q4 | 51.99 Million CAD | -16.9% |
| 2004 Q3 | 62.56 Million CAD | 5.95% |
| 2004 FY | - CAD | 20.21% |
| 2004 Q2 | 59.05 Million CAD | 15.84% |
| 2003 Q1 | 39.5 Million CAD | 0.0% |
| 2003 FY | - CAD | -26.28% |
| 2003 Q3 | 50.65 Million CAD | 9.93% |
| 2003 Q4 | 50.6 Million CAD | -0.09% |
| 2003 Q2 | 46.07 Million CAD | 16.64% |
| 2002 FY | - CAD | 11.7% |
| 2001 FY | - CAD | 14.36% |
| 2000 FY | - CAD | -13.71% |
| 1999 FY | - CAD | -31.52% |
| 1998 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 998.001% |
| Arem Pacific Corporation | 36.71 Thousand USD | -268542.244% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 87453.756% |
| BioCorRx Inc. | -2.68 Million USD | 3774.921% |
| Bionik Laboratories Corp. | -4.77 Million USD | 2165.284% |
| Banyan Corp. | 583.94 Thousand USD | -16790.719% |
| Clearday, Inc. | -7.53 Million USD | 1408.744% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -766092.807% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 9163.117% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 4563.413% |
| Selectis Health, Inc. | -7.29 Million USD | 1452.194% |
| Ethema Health Corporation | 2.07 Million USD | -4659.837% |
| HealthLynked Corp. | -2.75 Million USD | 3686.22% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 3815.811% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -341826.09% |
| Comjoyful International Company | 167.89 Thousand USD | -58646.24% |
| Medical Facilities Corporation | 77.94 Million USD | -26.541% |
| MedSmart Group Inc. | 47.8 Thousand USD | -206204.252% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 15923.4% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -9818.097% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 48993.075% |
| PAO Group, Inc. | 292.96 Thousand USD | -33567.05% |
| Primemd Inc. | 3.42 Million USD | -2778.135% |
| Raffles Medical Group Ltd | 100.7 Million USD | 2.054% |
| Ryman Healthcare Limited | -54.51 Million USD | 280.918% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 2330173.234% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 3507.863% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 17855.312% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 201389.796% |
| Veltex Corporation | -938.45 Thousand USD | 10610.018% |
| World Financial Holding Group | -28.43 Thousand USD | 347029.3% |
| Xcelerate Inc. | -2.53 Million USD | 3985.683% |